Literature DB >> 26454371

Zeroing in on zoster: A tale of many disorders produced by one virus.

Kristin M Galetta1, Don Gilden2.   

Abstract

While herpes zoster infection has been recognized since antiquity, chickenpox (varicella) was confused with smallpox until the 1800s, when both illnesses became better understood. In the 20th century, varicella zoster virus (VZV) was shown to cause varicella upon primary (first-time) infection and herpes zoster (shingles) after reactivation of latent VZV. Scientific progress over the past 50 years has rapidly advanced the understanding and prevention of disease produced by VZV. Combined imaging and virological studies continue to reveal the protean neurological, ocular and visceral disorders produced by VZV.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Infection; Neurologic disease; Vaccination; Varicella-zoster virus

Mesh:

Year:  2015        PMID: 26454371      PMCID: PMC4628852          DOI: 10.1016/j.jns.2015.10.004

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  73 in total

1.  The Use of the Electron Microscope in Diagnosis of Variola, Vaccinia, and Varicella.

Authors:  F P Nagler; G Rake
Journal:  J Bacteriol       Date:  1948-01       Impact factor: 3.490

Review 2.  Immunization in the adult immunocompromised host.

Authors:  Micha Löbermann; Denise Boršo; Inken Hilgendorf; Carlos Fritzsche; Uwe K Zettl; Emil C Reisinger
Journal:  Autoimmun Rev       Date:  2011-05-18       Impact factor: 9.754

Review 3.  Neurological disease produced by varicella zoster virus reactivation without rash.

Authors:  Don Gilden; Randall J Cohrs; Ravi Mahalingam; Maria A Nagel
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

4.  Restricted varicella-zoster virus transcription in human trigeminal ganglia obtained soon after death.

Authors:  Werner J D Ouwendijk; Alexander Choe; Maria A Nagel; Don Gilden; Albert D M E Osterhaus; Randall J Cohrs; Georges M G M Verjans
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

5.  Prevention of varicella by zoster immune globulin.

Authors:  P A Brunell; A Ross; L H Miller; B Kuo
Journal:  N Engl J Med       Date:  1969-05-29       Impact factor: 91.245

6.  Post-herpetic neuralgia: further post-mortem studies of cases with and without pain.

Authors:  C P N Watson; J H Deck; C Morshead; D Van der Kooy; R J Evans
Journal:  Pain       Date:  1991-02       Impact factor: 6.961

7.  Varicella-zoster virus vasculopathy: immune characteristics of virus-infected arteries.

Authors:  Maria A Nagel; Igor Traktinskiy; Kurt R Stenmark; Maria G Frid; Alexander Choe; Don Gilden
Journal:  Neurology       Date:  2012-12-12       Impact factor: 9.910

Review 8.  The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features.

Authors:  M A Nagel; R J Cohrs; R Mahalingam; M C Wellish; B Forghani; A Schiller; J E Safdieh; E Kamenkovich; L W Ostrow; M Levy; B Greenberg; A N Russman; I Katzan; C J Gardner; M Häusler; R Nau; T Saraya; H Wada; H Goto; M de Martino; M Ueno; W D Brown; C Terborg; D H Gilden
Journal:  Neurology       Date:  2008-03-11       Impact factor: 9.910

9.  Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox.

Authors:  M Brisson; N J Gay; W J Edmunds; N J Andrews
Journal:  Vaccine       Date:  2002-06-07       Impact factor: 3.641

10.  A case of meningitis due to varicella zoster virus reactivation in an immunocompetent child.

Authors:  Susanna Esposito; Samantha Bosis; Raffaella Pinzani; Laura Morlacchi; Laura Senatore; Nicola Principi
Journal:  Ital J Pediatr       Date:  2013-11-13       Impact factor: 2.638

View more
  5 in total

1.  Antiviral bioactivity of renewable polysaccharides against Varicella Zoster.

Authors:  Eiman Abu-Galiyun; Mahmoud Huleihel; Oshrat Levy-Ontman
Journal:  Cell Cycle       Date:  2019-11-14       Impact factor: 4.534

2.  Varicella-zoster virus meningitis with hypoglycorrhachia in a young immunocompetent adult without rash: A case report and literature review.

Authors:  Nikolaos Spernovasilis; Athanasia Milioni; Ioannis Gialamas; Evangelos Kokorakis; Garufallia Fanti
Journal:  IDCases       Date:  2018-04-13

Review 3.  Zoster sine herpete: a review.

Authors:  Junli Zhou; Juan Li; Lulin Ma; Song Cao
Journal:  Korean J Pain       Date:  2020-07-01

Review 4.  Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM).

Authors:  P Pedrazzoli; A Lasagna; I Cassaniti; A Ferrari; F Bergami; N Silvestris; E Sapuppo; M Di Maio; S Cinieri; F Baldanti
Journal:  ESMO Open       Date:  2022-07-16

Review 5.  Implementation of Hospital Policy for Healthcare Workers and Patients Exposed to Varicella-Zoster Virus.

Authors:  Si-Hyun Kim; Sun Hee Park; Su-Mi Choi; Dong-Gun Lee
Journal:  J Korean Med Sci       Date:  2018-08-27       Impact factor: 2.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.